malondialdehyde has been researched along with oxidopamine in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (8.11) | 18.2507 |
| 2000's | 2 (5.41) | 29.6817 |
| 2010's | 27 (72.97) | 24.3611 |
| 2020's | 5 (13.51) | 2.80 |
| Authors | Studies |
|---|---|
| Hsu, FF; Mattammal, MB; Strong, R; White, E | 1 |
| Jin, BK; Joo, WS; Kim, YS; Maeng, SH; Park, CW | 1 |
| Iwata-Ichikawa, E; Kabuto, H; Ogawa, N; Yokoi, I | 1 |
| Han, ES; Jang, YY; Kwon, OS; Lee, CS; Park, JW; Youn, YC | 1 |
| Korkach, IuP; Kotsiuruba, AV; Sahach, VF; Talanov, SA | 1 |
| Ju, WP; Li, ZG; Wang, DZ; Wang, YC; Xie, AM; Yu, YP | 1 |
| Asongalem, AE; Foyet, HS; Hritcu, L; Kamtchouing, P; Mihasan, M; Stefan, M | 1 |
| Ciobica, A; Hritcu, L; Olteanu, Z; Padurariu, M | 1 |
| Gupta, A; Kalonia, H; Kumar, A; Mishra, J; Sharma, N | 1 |
| Kopalli, SR; Koppula, S; Noh, SJ; Suh, YH | 1 |
| Andrade, GM; Carvalho, AC; Magalhães, HI; Moraes, MO; Morais, TC; Nobre-Júnior, HV; Rao, VS; Santos, FA; Trevisan, MT | 1 |
| Jalali-Nadoushan, M; Roghani, M | 1 |
| He, Q; Li, R; Liang, T; Xu, L; Zheng, N | 1 |
| Alirezaei, M; Rezaei, M | 1 |
| Li, M; Liu, X; Shao, R; Yang, G | 1 |
| Ba, YY; Guo, WW; Liu, HL; Wang, H; Wang, M; Wu, X; Yang, H; Zheng, L | 1 |
| Deng, X; Fang, X; Li, J; Li, S; Lu, Y; Xu, R; Zhang, J; Zhou, Y | 1 |
| An, D; Li, SL; Peng, Y; Sun, YP; Wang, DM; Xu, H; Yin, SM; Yu, DQ; Zhang, WQ; Zhao, D; Zhao, J | 1 |
| Chen, C; Fan, Q; Huang, J; Pan, X; Wei, H | 1 |
| Baluchnejadmojarad, T; Kiasalari, Z; Roghani, M | 1 |
| Sutalangka, C; Wattanathorn, J | 1 |
| Guo, SQ; Hu, ZW; Li, WL; Zou, XD | 1 |
| Haddadi, R; Jorjani, M; Khalifeh, S; Kheradmand, A; Nayebi, AM | 1 |
| Feng, Y; Olatunji, OJ; Olatunji, OO; Ouyang, Z; Su, Z; Tang, J | 1 |
| Dolatshahi, M; Farbood, Y; Khodadadi, A; Mansouri, SM; Sarkaki, A | 1 |
| Alipour Heidari, M; Dargahi, T; Faraji, A; Fraidouni, N; Haghdoost-Yazdi, H; Najafipour, R; Piri, H | 1 |
| Baluchnejadmojarad, T; Ghalami, J; Mansouri, M; Mokhtari, Z; Roghani, M | 1 |
| Baluchnejadmojarad, T; Rabiee, N; Roghani, M; Zabihnejad, S | 1 |
| Ju, B; Li, JF; Liu, YJ; Wang, HT; Wang, SS; Wang, YL; Yang, XP; Yin, HL; Zeng, ZL; Zhang, YZ | 1 |
| Babayan-Tazehkand, A; Dargahi, T; Haghdoost-Yazdi, H; Rastgoo, N; Sarbazi Golezari, A; Sarukhani, M | 1 |
| Meng, XB; Sun, DM; Sun, GB; Sun, XB; Wang, MX; Zhao, JY | 1 |
| Li, M; Lu, B; Song, H; Xu, T; Zhou, F | 1 |
| Azizi, Z; Farhadi, M; Manouchehrabadi, M; Torkaman-Boutorabi, A | 1 |
| Abolhassani, M; Juybari, KB; Mehrabani, M; Mirzamohammadi, S; Nematollahi, MH; Paseban, H; Saravani, M; Sharifi, AM; Tarzi, ME | 1 |
| Jiang, X; Qiao, B; Yue, Y | 1 |
| Ishiguro, T; Itoh, T; Kaba, N; Tsuda, S; Umemoto, H; Yasugi, S; Yoda, M | 1 |
| Mohajeri, D; Nourazar, MA; Sokouti, H | 1 |
37 other study(ies) available for malondialdehyde and oxidopamine
| Article | Year |
|---|---|
Characterization of peroxidative oxidation products of dopamine by mass spectrometry.
Topics: Acetylcysteine; Dopamine; Gas Chromatography-Mass Spectrometry; Horseradish Peroxidase; Hydrogen Peroxide; Malondialdehyde; Mass Spectrometry; NADPH-Ferrihemoprotein Reductase; Norepinephrine; Oxidation-Reduction; Oxidopamine; Serotonin | 1994 |
Melatonin increases striatal dopaminergic function in 6-OHDA-lesioned rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antioxidants; Corpus Striatum; Dopamine; Male; Malondialdehyde; Melatonin; Oxidopamine; Rats; Tyrosine 3-Monooxygenase | 1998 |
EPC-K1, a hydroxyl radical scavenger, prevents 6-hydroxydopamine-induced dopamine depletion in the mouse striatum by up-regulation of catalase activity.
Topics: 3,4-Dihydroxyphenylacetic Acid; Administration, Oral; Animals; Ascorbic Acid; Catalase; Cerebral Ventricles; Corpus Striatum; Dopamine; Free Radical Scavengers; Glutathione; Homovanillic Acid; Hydroxyl Radical; Injections, Intraventricular; Male; Malondialdehyde; Mice; Mice, Inbred ICR; Oxidopamine; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Vitamin E | 1999 |
Protective effect of serotonin on 6-hydroxydopamine- and dopamine-induced oxidative damage of brain mitochondria and synaptosomes and PC12 cells.
Topics: Animals; Brain; Calcium; Dopamine; Free Radical Scavengers; Hydrogen Peroxide; Intracellular Membranes; Male; Malondialdehyde; Melatonin; Mitochondria; Neuroprotective Agents; Oxidation-Reduction; Oxidative Stress; Oxidopamine; PC12 Cells; Permeability; Rats; Rats, Sprague-Dawley; Serotonin; Sulfhydryl Compounds; Superoxides; Synaptosomes | 2002 |
[Oxidative stress in the cardiovascular system of rats with chronic deficiency of cerebral dopamine].
Topics: Animals; Cardiovascular System; Cerebral Cortex; Corpus Striatum; Dopamine; Erythrocytes; Lipid Peroxidation; Male; Malondialdehyde; Mitochondria, Heart; Myocardium; Neurons; Oxidative Stress; Oxidopamine; Rats; Rats, Wistar; Reactive Oxygen Species; Substantia Nigra; Urea; Uric Acid | 2009 |
Acupuncture inhibits oxidative stress and rotational behavior in 6-hydroxydopamine lesioned rat.
Topics: Acupuncture Therapy; Adrenergic Agents; Animals; Brain; Brain Chemistry; Catalase; Glutathione Peroxidase; Male; Malondialdehyde; Oxidative Stress; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Wistar; Superoxide Dismutase | 2010 |
Neuroprotective effect of the methanolic extract of Hibiscus asper leaves in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Topics: Animals; Antioxidants; Apoptosis; Catalase; Disease Models, Animal; DNA Fragmentation; Dose-Response Relationship, Drug; Glutathione; Glutathione Peroxidase; Hibiscus; Injections, Intraperitoneal; Lipid Peroxidation; Male; Malondialdehyde; Medicine, African Traditional; Methanol; Neuroprotective Agents; Oxidopamine; Parkinsonian Disorders; Plant Extracts; Plant Leaves; Plants, Medicinal; Rats; Rats, Wistar; Solvents; Superoxide Dismutase; Temporal Lobe; Time Factors | 2011 |
The effects of pergolide on memory and oxidative stress in a rat model of Parkinson's disease.
Topics: Animals; Disease Models, Animal; Dopamine Agonists; Glutathione Peroxidase; Linear Models; Lipid Peroxidation; Male; Malondialdehyde; Maze Learning; Memory; Oxidative Stress; Oxidopamine; Parkinsonian Disorders; Pergolide; Rats; Rats, Wistar; Superoxide Dismutase; Temporal Lobe | 2012 |
Neuroprotective potential of atorvastatin and simvastatin (HMG-CoA reductase inhibitors) against 6-hydroxydopamine (6-OHDA) induced Parkinson-like symptoms.
Topics: Amphetamine; Analysis of Variance; Animals; Atorvastatin; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Enzyme-Linked Immunosorbent Assay; Glutathione; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-6; Male; Malondialdehyde; Mitochondria; Motor Activity; NADH Dehydrogenase; Nitrites; Oxidopamine; Parkinsonian Disorders; Pyrroles; Rats; Rats, Wistar; Simvastatin; Tetrazolium Salts; Thiazoles; Tumor Necrosis Factor-alpha | 2012 |
Methylparaben protects 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells and improved behavioral impairments in mouse model of Parkinson's disease.
Topics: Animals; Antioxidants; Avoidance Learning; Behavior, Animal; Cell Line, Tumor; Cognition; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Hydrogen Peroxide; Immunohistochemistry; Lipid Peroxidation; Male; Malondialdehyde; Maze Learning; Mice; Mice, Inbred C57BL; Motor Activity; Neurons; Neuroprotective Agents; Neurotoxicity Syndromes; Oxidative Stress; Oxidopamine; Parabens; Parkinsonian Disorders; Reactive Oxygen Species; Rotarod Performance Test; Tyrosine 3-Monooxygenase | 2013 |
Mangiferin ameliorates 6-hydroxydopamine-induced cytotoxicity and oxidative stress in ketamine model of schizophrenia.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Behavior, Animal; Brain; Cell Death; Cell Survival; Cells, Cultured; Female; Interleukin-6; Ketamine; Lipid Peroxidation; Male; Malondialdehyde; Mesencephalon; Mice; Motor Activity; Neuroprotective Agents; Neurotoxins; Nitrites; Oxidative Stress; Oxidopamine; Rats; Rats, Wistar; Schizophrenia; Xanthones | 2012 |
Alpha-lipoic acid protects against 6-hydroxydopamine-induced neurotoxicity in a rat model of hemi-parkinsonism.
Topics: Adrenergic Agents; Animals; Apomorphine; Disease Models, Animal; Dose-Response Relationship, Drug; Functional Laterality; Malondialdehyde; Neurons; Neuroprotective Agents; Oxidopamine; Parkinsonian Disorders; Rats; Rotation; Substantia Nigra; Thioctic Acid | 2013 |
Puerarin attenuates neuronal degeneration and blocks oxidative stress to elicit a neuroprotective effect on substantia nigra injury in 6-OHDA-lesioned rats.
Topics: Adrenergic Agents; Animals; Apomorphine; Brain Injuries; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation; Isoflavones; Male; Malondialdehyde; Microtubule-Associated Proteins; Motor Activity; NAD(P)H Dehydrogenase (Quinone); Nerve Degeneration; Neuroprotective Agents; Oxidative Stress; Oxidopamine; Oxidoreductases; Protein Deglycase DJ-1; Rats; Rats, Wistar; Substantia Nigra; Time Factors | 2013 |
Protective effects of Althaea officinalis L. extract in 6-hydroxydopamine-induced hemi-Parkinsonism model: behavioral, biochemical and histochemical evidence.
Topics: Althaea; Animals; Antiparkinson Agents; Behavior, Animal; Brain; Disease Models, Animal; Lipid Peroxidation; Male; Malondialdehyde; Neurons; Neuroprotective Agents; Oxidative Stress; Oxidopamine; Parkinsonian Disorders; Phytotherapy; Plant Extracts; Plant Leaves; Plants, Medicinal; Rats, Wistar; Time Factors | 2014 |
Edaravone protects neurons in the rat substantia nigra against 6-hydroxydopamine-induced oxidative stress damage.
Topics: Animals; Antipyrine; Behavior, Animal; Corpus Striatum; Edaravone; Glutathione; Male; Malondialdehyde; Neurons; Neuroprotective Agents; Oxidative Stress; Oxidopamine; Rats; Rats, Sprague-Dawley; Substantia Nigra | 2014 |
[Protective effect of alkaloids from Piper longum in rat dopaminergic neuron injury of 6-OHDA-induced Parkinson's disease].
Topics: Administration, Oral; Alkaloids; Animals; Apomorphine; Catalase; Dopamine Agonists; Dopaminergic Neurons; Glutathione; Glutathione Peroxidase; Male; Malondialdehyde; Motor Activity; Neostriatum; Nitric Oxide; Nitric Oxide Synthase; Oxidopamine; Parkinson Disease, Secondary; Piper; Random Allocation; Rats; Rats, Sprague-Dawley; Substantia Nigra; Superoxide Dismutase; Tyrosine 3-Monooxygenase | 2014 |
The possible mechanism of Parkinson's disease progressive damage and the preventive effect of GM1 in the rat model induced by 6-hydroxydopamine.
Topics: Animals; bcl-2-Associated X Protein; Brain; Calcium; Calmodulin; Disease Progression; G(M1) Ganglioside; Glutamic Acid; Infusions, Parenteral; Male; Malondialdehyde; Mitochondria; Neuroprotective Agents; Nitric Oxide Synthase Type I; Oxidopamine; Parkinsonian Disorders; Proto-Oncogene Proteins c-bcl-2; Rats, Wistar; Trace Elements | 2014 |
Neuroprotection by scorpion venom heat resistant peptide in 6-hydroxydopamine rat model of early-stage Parkinson's disease.
Topics: Animals; Antioxidants; Corpus Striatum; Disease Models, Animal; Dopaminergic Neurons; Malondialdehyde; Mesencephalon; Mitochondria; Neuroprotective Agents; Oxidative Stress; Oxidopamine; Parkinson Disease; Peptides; Rats; Rats, Sprague-Dawley; Scorpion Venoms; Superoxide Dismutase | 2014 |
Neuroprotective effect of combined therapy with hyperbaric oxygen and madopar on 6-hydroxydopamine-induced Parkinson's disease in rats.
Topics: Animals; Apomorphine; Benserazide; Combined Modality Therapy; Drug Combinations; Glial Fibrillary Acidic Protein; Glutathione Peroxidase; Hyperbaric Oxygenation; Levodopa; Lipid Peroxidation; Male; Malondialdehyde; Nerve Degeneration; Neuroprotective Agents; Oxidative Stress; Oxidopamine; Parkinson Disease; Proto-Oncogene Proteins c-bcl-2; Rats, Wistar; Stereotyped Behavior; Substantia Nigra; Superoxide Dismutase; Tyrosine 3-Monooxygenase | 2015 |
Hypericum Perforatum Hydroalcoholic Extract Mitigates Motor Dysfunction and is Neuroprotective in Intrastriatal 6-Hydroxydopamine Rat Model of Parkinson's Disease.
Topics: Animals; Apomorphine; Catalase; Corpus Striatum; Disease Models, Animal; Ethanol; Glutathione; Hypericum; Male; Malondialdehyde; Mitogen-Activated Protein Kinases; Motor Activity; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Plant Extracts; Rats, Wistar; Reaction Time; Tumor Necrosis Factor-alpha; Tyrosine 3-Monooxygenase; Water | 2016 |
Novel Food Supplement "CP1" Improves Motor Deficit, Cognitive Function, and Neurodegeneration in Animal Model of Parkinson's Disease.
Topics: Acetylcholinesterase; Animals; Behavior, Animal; Brain; Cholinergic Neurons; Cognition; Cyperus; Dietary Supplements; Disease Models, Animal; Dopaminergic Neurons; Functional Food; GPI-Linked Proteins; Male; Malondialdehyde; Monoamine Oxidase; Motor Activity; Nerve Degeneration; Oxidative Stress; Oxidopamine; Parkinson Disease, Secondary; Plant Extracts; Rats, Wistar; Spatial Memory; Time Factors; Tyrosine 3-Monooxygenase; Zingiber officinale | 2016 |
NAMPT protects against 6-hydroxydopamine-induced neurotoxicity in PC12 cells through modulating SIRT1 activity.
Topics: Acrylamides; Animals; Cell Survival; Cytokines; L-Lactate Dehydrogenase; Malondialdehyde; Nicotinamide Mononucleotide; Nicotinamide Phosphoribosyltransferase; Oxidopamine; Parkinson Disease, Secondary; PC12 Cells; Piperidines; Rats; Sirtuin 1 | 2016 |
Effects of WR1065 on 6-hydroxydopamine-induced motor imbalance: Possible involvement of oxidative stress and inflammatory cytokines.
Topics: Animals; Disease Models, Animal; Glutathione; Inflammation; Interleukin-1beta; Lipid Peroxidation; Male; Malondialdehyde; Mercaptoethylamines; Motor Activity; Neuroprotective Agents; Oxidative Stress; Oxidopamine; Parkinsonian Disorders; Pars Compacta; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2016 |
Cordycepin protects PC12 cells against 6-hydroxydopamine induced neurotoxicity via its antioxidant properties.
Topics: Animals; Antioxidants; Apoptosis; Caspase 3; Cell Survival; Deoxyadenosines; Enzyme Activation; Glutathione Peroxidase; Lipid Peroxidation; Malondialdehyde; Membrane Potential, Mitochondrial; Neuroprotection; Neuroprotective Agents; Neurotoxins; Oxidopamine; PC12 Cells; Rats; Reactive Oxygen Species; Superoxide Dismutase | 2016 |
Neuroprotective Effects of Ellagic Acid in a Rat Model of Parkinson's Disease.
Topics: Animals; Antioxidants; Brain; Corpus Striatum; Ellagic Acid; Glutathione Peroxidase; Male; Malondialdehyde; Medial Forebrain Bundle; Models, Animal; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Rats; Rats, Wistar | 2016 |
Blockade of fast A-type and TEA-sensitive potassium channels provide an antiparkinsonian effect in a 6-OHDA animal model.
Topics: 4-Aminopyridine; Animals; Antiparkinson Agents; Apomorphine; Dose-Response Relationship, Drug; Drug Synergism; Male; Malondialdehyde; Medial Forebrain Bundle; Neuroprotective Agents; Oxidopamine; Parkinson Disease, Secondary; Potassium Channel Blockers; Rats; Rotarod Performance Test; Tetraethylammonium | 2017 |
Sesamin imparts neuroprotection against intrastriatal 6-hydroxydopamine toxicity by inhibition of astroglial activation, apoptosis, and oxidative stress.
Topics: Animals; Apoptosis; Astrocytes; Behavior, Animal; Caspase 3; Dioxoles; Gliosis; Lignans; Male; Malondialdehyde; Neostriatum; Neuroprotective Agents; Oxidative Stress; Oxidopamine; Parkinson Disease, Secondary; Postural Balance; Rats; Rats, Wistar; Reactive Oxygen Species; Superoxide Dismutase | 2017 |
Ellagic acid exerts protective effect in intrastriatal 6-hydroxydopamine rat model of Parkinson's disease: Possible involvement of ERβ/Nrf2/HO-1 signaling.
Topics: Animals; Antioxidants; Apoptosis; Corpus Striatum; Dopaminergic Neurons; Ellagic Acid; Estrogen Receptor beta; Heme Oxygenase (Decyclizing); Malondialdehyde; Models, Animal; Monoamine Oxidase; Neostriatum; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidative Stress; Oxidopamine; Parkinson Disease; Pars Compacta; Rats; Reactive Oxygen Species; Signal Transduction; Substantia Nigra | 2017 |
Protective Effect of Curcumin Against Oxidative Stress-Induced Injury in Rats with Parkinson's Disease Through the Wnt/ β-Catenin Signaling Pathway.
Topics: Animals; Apoptosis; Astrocytes; Behavior, Animal; beta Catenin; Cell Adhesion; Cells, Cultured; Curcumin; Cyclin D1; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Glial Fibrillary Acidic Protein; Glutathione Peroxidase; Immunohistochemistry; Intercellular Signaling Peptides and Proteins; Male; Malondialdehyde; Membrane Potential, Mitochondrial; Oxidative Stress; Oxidopamine; Parkinson Disease; Protective Agents; Proto-Oncogene Proteins c-myc; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Tyrosine 3-Monooxygenase; Wnt Signaling Pathway; Wnt3 Protein | 2017 |
Evaluation of the antiparkinsonism and neuroprotective effects of hydrogen sulfide in acute 6-hydroxydopamine-induced animal model of Parkinson's disease: behavioral, histological and biochemical studies.
Topics: Analysis of Variance; Animals; Apomorphine; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Glutathione Peroxidase; Hydrogen Sulfide; Male; Malondialdehyde; Motor Activity; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Postural Balance; Rats; Rats, Wistar; Rotarod Performance Test; Superoxide Dismutase; Sympatholytics | 2018 |
[Protective effects and underlying mechanisms of Panax notoginseng saponins against SH-SY5Y cell apoptosis induced by 6-hydroxydopamine].
Topics: Apoptosis; Caspase 3; Cell Line, Tumor; Cell Survival; Glutathione Peroxidase; Humans; Malondialdehyde; Membrane Potential, Mitochondrial; Oxidative Stress; Oxidopamine; Panax notoginseng; Reactive Oxygen Species; Saponins; Superoxide Dismutase | 2016 |
Acteoside protects against 6-OHDA-induced dopaminergic neuron damage via Nrf2-ARE signaling pathway.
Topics: Animals; Antioxidants; Carboxylic Ester Hydrolases; Dopaminergic Neurons; Gene Expression Regulation, Enzymologic; Glucosides; Larva; Malondialdehyde; Metabolic Networks and Pathways; Motor Activity; NF-E2-Related Factor 2; Oxidopamine; Phenols; Zebrafish; Zebrafish Proteins | 2018 |
Carvacrol Protects Against 6-Hydroxydopamine-Induced Neurotoxicity in In Vivo and In Vitro Models of Parkinson's Disease.
Topics: Animals; Annexins; Behavior, Animal; Cell Survival; Corpus Striatum; Cymenes; Dose-Response Relationship, Drug; Glutathione; Lipid Peroxidation; Male; Malondialdehyde; Nerve Degeneration; Neuroprotective Agents; Oxidopamine; Parkinson Disease, Secondary; PC12 Cells; Rats; Reactive Oxygen Species | 2020 |
Protective effect of hydralazine on a cellular model of Parkinson's disease: a possible role of hypoxia-inducible factor (HIF)-1α.
Topics: Antioxidants; Apoptosis; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Dopamine; Humans; Hydralazine; Hypoxia-Inducible Factor 1, alpha Subunit; Malondialdehyde; Nitric Oxide; Oxidopamine; Parkinson Disease; Superoxide Dismutase | 2020 |
Tormentic acid confers protection against oxidative stress injury in rats with Parkinson's disease by targeting the Wnt/β-catenin signaling pathway.
Topics: Animals; Behavior, Animal; Cell Survival; Female; Glutathione Peroxidase; Male; Malondialdehyde; Memory; Neuroprotective Agents; Oxidative Stress; Oxidopamine; Parkinson Disease; PC12 Cells; Rats; Rats, Wistar; RNA, Messenger; Superoxide Dismutase; Triterpenes; Wnt Signaling Pathway | 2020 |
Protective Effect of Nervonic Acid Against 6-Hydroxydopamine-Induced Oxidative Stress in PC-12 Cells.
Topics: Animals; Antioxidants; Brain; Cell Membrane; Cell Survival; Fatty Acids, Monounsaturated; Glutamate-Cysteine Ligase; Glutathione; Lipid Bilayers; Lipid Peroxidation; Malondialdehyde; Neuroprotective Agents; Oxidative Stress; Oxidopamine; Parkinson Disease; PC12 Cells; Rats; Superoxide Dismutase | 2021 |
6-Hydroxydopamine-Induced Neurotoxicity in Rat Model of Parkinson's Disease: Is Reversed via Anti-Oxidative Activities of Curcumin and Aerobic Exercise Therapy.
Topics: alpha-Synuclein; Animals; Antioxidants; Apomorphine; Curcumin; Disease Models, Animal; Glutathione Peroxidase; Malondialdehyde; Neuroprotective Agents; Neurotoxicity Syndromes; Neurotoxins; Oxidopamine; Parkinson Disease; Rats; Substantia Nigra | 2022 |